rs750242262
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_000171.4(GLRA1):c.605G>A(p.Gly202Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000118 in 1,613,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G202R) has been classified as Uncertain significance.
Frequency
Consequence
NM_000171.4 missense
Scores
Clinical Significance
Conservation
Publications
- hyperekplexia 1Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- hereditary hyperekplexiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000171.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GLRA1 | NM_000171.4 | MANE Select | c.605G>A | p.Gly202Glu | missense | Exon 6 of 9 | NP_000162.2 | ||
| GLRA1 | NM_001146040.2 | c.605G>A | p.Gly202Glu | missense | Exon 6 of 9 | NP_001139512.1 | |||
| GLRA1 | NM_001292000.2 | c.356G>A | p.Gly119Glu | missense | Exon 5 of 8 | NP_001278929.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GLRA1 | ENST00000274576.9 | TSL:1 MANE Select | c.605G>A | p.Gly202Glu | missense | Exon 6 of 9 | ENSP00000274576.5 | ||
| GLRA1 | ENST00000455880.2 | TSL:1 | c.605G>A | p.Gly202Glu | missense | Exon 6 of 9 | ENSP00000411593.2 | ||
| GLRA1 | ENST00000462581.6 | TSL:1 | n.*363G>A | non_coding_transcript_exon | Exon 5 of 8 | ENSP00000430595.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251486 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461690Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727170 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74322 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.605G>A (p.G202E) alteration is located in exon 6 (coding exon 6) of the GLRA1 gene. This alteration results from a G to A substitution at nucleotide position 605, causing the glycine (G) at amino acid position 202 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Hereditary hyperekplexia Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 202 of the GLRA1 protein (p.Gly202Glu). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GLRA1 protein function. ClinVar contains an entry for this variant (Variation ID: 532837). This variant has not been reported in the literature in individuals affected with GLRA1-related conditions. This variant is present in population databases (rs750242262, gnomAD 0.003%).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at